Medartis Holding AG
Medartis Holding AG (MDRSF) Stock Competitors & Peer Comparison
See (MDRSF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MDRSF | $115.00 | +0.00% | 1.4B | 135.29 | $0.85 | N/A |
| SEMHF | $39.95 | -0.61% | 44.6B | 18.08 | $2.21 | +2.98% |
| RYLPF | $26.93 | +2.35% | 25.6B | 23.02 | $1.17 | +3.53% |
| SMMNY | $19.86 | -0.25% | 22.1B | 17.81 | $1.11 | +3.00% |
| SONVF | $232.34 | +1.29% | 13.8B | 20.86 | $11.14 | +2.33% |
| SONVY | $45.60 | -1.06% | 13.7B | 20.65 | $2.23 | +2.34% |
| SNNUF | $14.95 | -3.86% | 12.8B | 20.76 | $0.72 | +2.63% |
| WILYY | $18.87 | +6.01% | 7.7B | 20.80 | $0.88 | N/A |
| WILLF | $34.10 | +0.00% | 7.2B | 19.49 | $1.75 | N/A |
| GNGBF | $23.23 | +0.00% | 5.9B | 25.25 | $0.92 | +2.22% |
Stock Comparison
MDRSF vs SEMHF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, SEMHF has a market cap of 44.6B. Regarding current trading prices, MDRSF is priced at $115.00, while SEMHF trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas SEMHF's P/E ratio is 18.08. In terms of profitability, MDRSF's ROE is +0.03%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, MDRSF is less volatile compared to SEMHF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check SEMHF's competition here
MDRSF vs RYLPF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, RYLPF has a market cap of 25.6B. Regarding current trading prices, MDRSF is priced at $115.00, while RYLPF trades at $26.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas RYLPF's P/E ratio is 23.02. In terms of profitability, MDRSF's ROE is +0.03%, compared to RYLPF's ROE of +0.09%. Regarding short-term risk, MDRSF and RYLPF have similar daily volatility (0.00).Check RYLPF's competition here
MDRSF vs SMMNY Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, SMMNY has a market cap of 22.1B. Regarding current trading prices, MDRSF is priced at $115.00, while SMMNY trades at $19.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas SMMNY's P/E ratio is 17.81. In terms of profitability, MDRSF's ROE is +0.03%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, MDRSF is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check SMMNY's competition here
MDRSF vs SONVF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, SONVF has a market cap of 13.8B. Regarding current trading prices, MDRSF is priced at $115.00, while SONVF trades at $232.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas SONVF's P/E ratio is 20.86. In terms of profitability, MDRSF's ROE is +0.03%, compared to SONVF's ROE of +0.20%. Regarding short-term risk, MDRSF and SONVF have similar daily volatility (0.00).Check SONVF's competition here
MDRSF vs SONVY Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, SONVY has a market cap of 13.7B. Regarding current trading prices, MDRSF is priced at $115.00, while SONVY trades at $45.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas SONVY's P/E ratio is 20.65. In terms of profitability, MDRSF's ROE is +0.03%, compared to SONVY's ROE of +0.20%. Regarding short-term risk, MDRSF is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check SONVY's competition here
MDRSF vs SNNUF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, SNNUF has a market cap of 12.8B. Regarding current trading prices, MDRSF is priced at $115.00, while SNNUF trades at $14.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas SNNUF's P/E ratio is 20.76. In terms of profitability, MDRSF's ROE is +0.03%, compared to SNNUF's ROE of +0.12%. Regarding short-term risk, MDRSF and SNNUF have similar daily volatility (0.00).Check SNNUF's competition here
MDRSF vs WILYY Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, WILYY has a market cap of 7.7B. Regarding current trading prices, MDRSF is priced at $115.00, while WILYY trades at $18.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas WILYY's P/E ratio is 20.80. In terms of profitability, MDRSF's ROE is +0.03%, compared to WILYY's ROE of +0.16%. Regarding short-term risk, MDRSF and WILYY have similar daily volatility (0.00).Check WILYY's competition here
MDRSF vs WILLF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, WILLF has a market cap of 7.2B. Regarding current trading prices, MDRSF is priced at $115.00, while WILLF trades at $34.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas WILLF's P/E ratio is 19.49. In terms of profitability, MDRSF's ROE is +0.03%, compared to WILLF's ROE of +0.16%. Regarding short-term risk, MDRSF is less volatile compared to WILLF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check WILLF's competition here
MDRSF vs GNGBF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, GNGBF has a market cap of 5.9B. Regarding current trading prices, MDRSF is priced at $115.00, while GNGBF trades at $23.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas GNGBF's P/E ratio is 25.25. In terms of profitability, MDRSF's ROE is +0.03%, compared to GNGBF's ROE of +0.08%. Regarding short-term risk, MDRSF and GNGBF have similar daily volatility (0.00).Check GNGBF's competition here
MDRSF vs GNGBY Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, GNGBY has a market cap of 5.6B. Regarding current trading prices, MDRSF is priced at $115.00, while GNGBY trades at $20.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas GNGBY's P/E ratio is 21.94. In terms of profitability, MDRSF's ROE is +0.03%, compared to GNGBY's ROE of +0.08%. Regarding short-term risk, MDRSF and GNGBY have similar daily volatility (0.00).Check GNGBY's competition here
MDRSF vs CHEOF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, CHEOF has a market cap of 4.7B. Regarding current trading prices, MDRSF is priced at $115.00, while CHEOF trades at $72.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas CHEOF's P/E ratio is 18.98. In terms of profitability, MDRSF's ROE is +0.03%, compared to CHEOF's ROE of +0.18%. Regarding short-term risk, MDRSF is less volatile compared to CHEOF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check CHEOF's competition here
MDRSF vs CHEOY Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, CHEOY has a market cap of 4.7B. Regarding current trading prices, MDRSF is priced at $115.00, while CHEOY trades at $36.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas CHEOY's P/E ratio is 18.96. In terms of profitability, MDRSF's ROE is +0.03%, compared to CHEOY's ROE of +0.18%. Regarding short-term risk, MDRSF is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check CHEOY's competition here
MDRSF vs AMBFF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, AMBFF has a market cap of 3.4B. Regarding current trading prices, MDRSF is priced at $115.00, while AMBFF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas AMBFF's P/E ratio is 46.43. In terms of profitability, MDRSF's ROE is +0.03%, compared to AMBFF's ROE of +0.08%. Regarding short-term risk, MDRSF and AMBFF have similar daily volatility (0.00).Check AMBFF's competition here
MDRSF vs NHNKY Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, NHNKY has a market cap of 3B. Regarding current trading prices, MDRSF is priced at $115.00, while NHNKY trades at $9.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas NHNKY's P/E ratio is 13.03. In terms of profitability, MDRSF's ROE is +0.03%, compared to NHNKY's ROE of +0.07%. Regarding short-term risk, MDRSF and NHNKY have similar daily volatility (0.00).Check NHNKY's competition here
MDRSF vs AMBBY Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, AMBBY has a market cap of 2.6B. Regarding current trading prices, MDRSF is priced at $115.00, while AMBBY trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas AMBBY's P/E ratio is 35.64. In terms of profitability, MDRSF's ROE is +0.03%, compared to AMBBY's ROE of +0.08%. Regarding short-term risk, MDRSF and AMBBY have similar daily volatility (0.00).Check AMBBY's competition here
MDRSF vs GNNDY Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, GNNDY has a market cap of 2.2B. Regarding current trading prices, MDRSF is priced at $115.00, while GNNDY trades at $45.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas GNNDY's P/E ratio is 53.08. In terms of profitability, MDRSF's ROE is +0.03%, compared to GNNDY's ROE of -0.04%. Regarding short-term risk, MDRSF is less volatile compared to GNNDY. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check GNNDY's competition here
MDRSF vs MCRPF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, MCRPF has a market cap of 2.2B. Regarding current trading prices, MDRSF is priced at $115.00, while MCRPF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas MCRPF's P/E ratio is -12.67. In terms of profitability, MDRSF's ROE is +0.03%, compared to MCRPF's ROE of +0.06%. Regarding short-term risk, MDRSF and MCRPF have similar daily volatility (0.00).Check MCRPF's competition here
MDRSF vs GGNDF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, GGNDF has a market cap of 2.1B. Regarding current trading prices, MDRSF is priced at $115.00, while GGNDF trades at $14.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas GGNDF's P/E ratio is 51.25. In terms of profitability, MDRSF's ROE is +0.03%, compared to GGNDF's ROE of -0.04%. Regarding short-term risk, MDRSF and GGNDF have similar daily volatility (0.00).Check GGNDF's competition here
MDRSF vs DRWKF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, DRWKF has a market cap of 2.1B. Regarding current trading prices, MDRSF is priced at $115.00, while DRWKF trades at $111.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas DRWKF's P/E ratio is 11.64. In terms of profitability, MDRSF's ROE is +0.03%, compared to DRWKF's ROE of +0.10%. Regarding short-term risk, MDRSF and DRWKF have similar daily volatility (0.00).Check DRWKF's competition here
MDRSF vs OSSFF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, OSSFF has a market cap of 1.8B. Regarding current trading prices, MDRSF is priced at $115.00, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas OSSFF's P/E ratio is 20.75. In terms of profitability, MDRSF's ROE is +0.03%, compared to OSSFF's ROE of +0.10%. Regarding short-term risk, MDRSF and OSSFF have similar daily volatility (0.00).Check OSSFF's competition here
MDRSF vs DWRKF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, MDRSF is priced at $115.00, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, MDRSF's ROE is +0.03%, compared to DWRKF's ROE of N/A. Regarding short-term risk, MDRSF and DWRKF have similar daily volatility (0.00).Check DWRKF's competition here
MDRSF vs NHNKF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, NHNKF has a market cap of 1.7B. Regarding current trading prices, MDRSF is priced at $115.00, while NHNKF trades at $10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas NHNKF's P/E ratio is 30.28. In terms of profitability, MDRSF's ROE is +0.03%, compared to NHNKF's ROE of +0.07%. Regarding short-term risk, MDRSF and NHNKF have similar daily volatility (0.00).Check NHNKF's competition here
MDRSF vs STSEY Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, STSEY has a market cap of 1.7B. Regarding current trading prices, MDRSF is priced at $115.00, while STSEY trades at $5.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas STSEY's P/E ratio is 18.37. In terms of profitability, MDRSF's ROE is +0.03%, compared to STSEY's ROE of -0.00%. Regarding short-term risk, MDRSF and STSEY have similar daily volatility (0.00).Check STSEY's competition here
MDRSF vs MEDGF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, MDRSF is priced at $115.00, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, MDRSF's ROE is +0.03%, compared to MEDGF's ROE of +0.22%. Regarding short-term risk, MDRSF and MEDGF have similar daily volatility (0.00).Check MEDGF's competition here
MDRSF vs OSSUY Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, OSSUY has a market cap of 1.6B. Regarding current trading prices, MDRSF is priced at $115.00, while OSSUY trades at $3.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas OSSUY's P/E ratio is 19.08. In terms of profitability, MDRSF's ROE is +0.03%, compared to OSSUY's ROE of +0.10%. Regarding short-term risk, MDRSF and OSSUY have similar daily volatility (0.00).Check OSSUY's competition here
MDRSF vs DGWPF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, DGWPF has a market cap of 1.6B. Regarding current trading prices, MDRSF is priced at $115.00, while DGWPF trades at $83.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas DGWPF's P/E ratio is 8.70. In terms of profitability, MDRSF's ROE is +0.03%, compared to DGWPF's ROE of +0.10%. Regarding short-term risk, MDRSF and DGWPF have similar daily volatility (0.00).Check DGWPF's competition here
MDRSF vs VTRLY Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, VTRLY has a market cap of 1.5B. Regarding current trading prices, MDRSF is priced at $115.00, while VTRLY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas VTRLY's P/E ratio is -2.75. In terms of profitability, MDRSF's ROE is +0.03%, compared to VTRLY's ROE of -0.47%. Regarding short-term risk, MDRSF and VTRLY have similar daily volatility (0.00).Check VTRLY's competition here
MDRSF vs FDMDF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, FDMDF has a market cap of 1.5B. Regarding current trading prices, MDRSF is priced at $115.00, while FDMDF trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas FDMDF's P/E ratio is -8.62. In terms of profitability, MDRSF's ROE is +0.03%, compared to FDMDF's ROE of -9.21%. Regarding short-term risk, MDRSF and FDMDF have similar daily volatility (0.00).Check FDMDF's competition here
MDRSF vs LFTSF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, LFTSF has a market cap of 858.1M. Regarding current trading prices, MDRSF is priced at $115.00, while LFTSF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas LFTSF's P/E ratio is 19.50. In terms of profitability, MDRSF's ROE is +0.03%, compared to LFTSF's ROE of +0.02%. Regarding short-term risk, MDRSF is less volatile compared to LFTSF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check LFTSF's competition here
MDRSF vs ELEAF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, ELEAF has a market cap of 759.8M. Regarding current trading prices, MDRSF is priced at $115.00, while ELEAF trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas ELEAF's P/E ratio is 12.99. In terms of profitability, MDRSF's ROE is +0.03%, compared to ELEAF's ROE of +0.16%. Regarding short-term risk, MDRSF is less volatile compared to ELEAF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check ELEAF's competition here
MDRSF vs XVIPF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, XVIPF has a market cap of 718.5M. Regarding current trading prices, MDRSF is priced at $115.00, while XVIPF trades at $22.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas XVIPF's P/E ratio is 91.24. In terms of profitability, MDRSF's ROE is +0.03%, compared to XVIPF's ROE of +0.03%. Regarding short-term risk, MDRSF and XVIPF have similar daily volatility (0.00).Check XVIPF's competition here
MDRSF vs BRSYF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, BRSYF has a market cap of 542.4M. Regarding current trading prices, MDRSF is priced at $115.00, while BRSYF trades at $13.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas BRSYF's P/E ratio is 75.28. In terms of profitability, MDRSF's ROE is +0.03%, compared to BRSYF's ROE of +0.11%. Regarding short-term risk, MDRSF is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check BRSYF's competition here
MDRSF vs IOBCF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, IOBCF has a market cap of 501.1M. Regarding current trading prices, MDRSF is priced at $115.00, while IOBCF trades at $17.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas IOBCF's P/E ratio is 33.53. In terms of profitability, MDRSF's ROE is +0.03%, compared to IOBCF's ROE of +0.10%. Regarding short-term risk, MDRSF and IOBCF have similar daily volatility (0.00).Check IOBCF's competition here
MDRSF vs AVMR Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, MDRSF is priced at $115.00, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas AVMR's P/E ratio is -18.34. In terms of profitability, MDRSF's ROE is +0.03%, compared to AVMR's ROE of -0.30%. Regarding short-term risk, MDRSF and AVMR have similar daily volatility (0.00).Check AVMR's competition here
MDRSF vs DMTRF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, DMTRF has a market cap of 476M. Regarding current trading prices, MDRSF is priced at $115.00, while DMTRF trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas DMTRF's P/E ratio is -198.00. In terms of profitability, MDRSF's ROE is +0.03%, compared to DMTRF's ROE of +0.36%. Regarding short-term risk, MDRSF and DMTRF have similar daily volatility (0.00).Check DMTRF's competition here
MDRSF vs CALZF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, CALZF has a market cap of 414.5M. Regarding current trading prices, MDRSF is priced at $115.00, while CALZF trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas CALZF's P/E ratio is 60.00. In terms of profitability, MDRSF's ROE is +0.03%, compared to CALZF's ROE of +0.12%. Regarding short-term risk, MDRSF and CALZF have similar daily volatility (0.00).Check CALZF's competition here
MDRSF vs HYBT Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, MDRSF is priced at $115.00, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas HYBT's P/E ratio is N/A. In terms of profitability, MDRSF's ROE is +0.03%, compared to HYBT's ROE of +0.02%. Regarding short-term risk, MDRSF and HYBT have similar daily volatility (0.00).Check HYBT's competition here
MDRSF vs CYBQY Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, CYBQY has a market cap of 356.7M. Regarding current trading prices, MDRSF is priced at $115.00, while CYBQY trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas CYBQY's P/E ratio is -200.00. In terms of profitability, MDRSF's ROE is +0.03%, compared to CYBQY's ROE of -0.00%. Regarding short-term risk, MDRSF and CYBQY have similar daily volatility (0.00).Check CYBQY's competition here
MDRSF vs CLVSF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, CLVSF has a market cap of 321.8M. Regarding current trading prices, MDRSF is priced at $115.00, while CLVSF trades at $13.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas CLVSF's P/E ratio is 22.11. In terms of profitability, MDRSF's ROE is +0.03%, compared to CLVSF's ROE of +0.15%. Regarding short-term risk, MDRSF and CLVSF have similar daily volatility (0.00).Check CLVSF's competition here
MDRSF vs CSSPF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, CSSPF has a market cap of 273.5M. Regarding current trading prices, MDRSF is priced at $115.00, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas CSSPF's P/E ratio is 32.50. In terms of profitability, MDRSF's ROE is +0.03%, compared to CSSPF's ROE of +0.10%. Regarding short-term risk, MDRSF is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check CSSPF's competition here
MDRSF vs CYBQF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, CYBQF has a market cap of 246.8M. Regarding current trading prices, MDRSF is priced at $115.00, while CYBQF trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas CYBQF's P/E ratio is -185.00. In terms of profitability, MDRSF's ROE is +0.03%, compared to CYBQF's ROE of -0.00%. Regarding short-term risk, MDRSF and CYBQF have similar daily volatility (0.00).Check CYBQF's competition here
MDRSF vs HTLZF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, MDRSF is priced at $115.00, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, MDRSF's ROE is +0.03%, compared to HTLZF's ROE of -0.01%. Regarding short-term risk, MDRSF and HTLZF have similar daily volatility (0.00).Check HTLZF's competition here
MDRSF vs IMPZY Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, IMPZY has a market cap of 229.3M. Regarding current trading prices, MDRSF is priced at $115.00, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, MDRSF's ROE is +0.03%, compared to IMPZY's ROE of +8.77%. Regarding short-term risk, MDRSF and IMPZY have similar daily volatility (0.00).Check IMPZY's competition here
MDRSF vs VMTHF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, VMTHF has a market cap of 186.1M. Regarding current trading prices, MDRSF is priced at $115.00, while VMTHF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas VMTHF's P/E ratio is -3.01. In terms of profitability, MDRSF's ROE is +0.03%, compared to VMTHF's ROE of -0.21%. Regarding short-term risk, MDRSF and VMTHF have similar daily volatility (0.00).Check VMTHF's competition here
MDRSF vs DTXMF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, MDRSF is priced at $115.00, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, MDRSF's ROE is +0.03%, compared to DTXMF's ROE of -0.74%. Regarding short-term risk, MDRSF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check DTXMF's competition here
MDRSF vs BCCOY Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, BCCOY has a market cap of 165.4M. Regarding current trading prices, MDRSF is priced at $115.00, while BCCOY trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas BCCOY's P/E ratio is -1.03. In terms of profitability, MDRSF's ROE is +0.03%, compared to BCCOY's ROE of -0.51%. Regarding short-term risk, MDRSF and BCCOY have similar daily volatility (0.00).Check BCCOY's competition here
MDRSF vs BRNHF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, BRNHF has a market cap of 161.7M. Regarding current trading prices, MDRSF is priced at $115.00, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, MDRSF's ROE is +0.03%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, MDRSF is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check BRNHF's competition here
MDRSF vs CLLKF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, CLLKF has a market cap of 157.5M. Regarding current trading prices, MDRSF is priced at $115.00, while CLLKF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas CLLKF's P/E ratio is -1.00. In terms of profitability, MDRSF's ROE is +0.03%, compared to CLLKF's ROE of -0.52%. Regarding short-term risk, MDRSF and CLLKF have similar daily volatility (0.00).Check CLLKF's competition here
MDRSF vs EKDHF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, EKDHF has a market cap of 150.5M. Regarding current trading prices, MDRSF is priced at $115.00, while EKDHF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas EKDHF's P/E ratio is 34.96. In terms of profitability, MDRSF's ROE is +0.03%, compared to EKDHF's ROE of +0.03%. Regarding short-term risk, MDRSF and EKDHF have similar daily volatility (0.00).Check EKDHF's competition here
MDRSF vs EAPIF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, EAPIF has a market cap of 147.5M. Regarding current trading prices, MDRSF is priced at $115.00, while EAPIF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas EAPIF's P/E ratio is -0.59. In terms of profitability, MDRSF's ROE is +0.03%, compared to EAPIF's ROE of -0.24%. Regarding short-term risk, MDRSF and EAPIF have similar daily volatility (0.00).Check EAPIF's competition here
MDRSF vs AMEUF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, MDRSF is priced at $115.00, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, MDRSF's ROE is +0.03%, compared to AMEUF's ROE of -1.90%. Regarding short-term risk, MDRSF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check AMEUF's competition here
MDRSF vs PXMBF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, PXMBF has a market cap of 119.9M. Regarding current trading prices, MDRSF is priced at $115.00, while PXMBF trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas PXMBF's P/E ratio is 23.33. In terms of profitability, MDRSF's ROE is +0.03%, compared to PXMBF's ROE of -0.04%. Regarding short-term risk, MDRSF is less volatile compared to PXMBF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check PXMBF's competition here
MDRSF vs SNZZF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, SNZZF has a market cap of 110.1M. Regarding current trading prices, MDRSF is priced at $115.00, while SNZZF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas SNZZF's P/E ratio is -7.78. In terms of profitability, MDRSF's ROE is +0.03%, compared to SNZZF's ROE of -0.38%. Regarding short-term risk, MDRSF and SNZZF have similar daily volatility (0.00).Check SNZZF's competition here
MDRSF vs AVHHL Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, AVHHL has a market cap of 102.7M. Regarding current trading prices, MDRSF is priced at $115.00, while AVHHL trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas AVHHL's P/E ratio is -2.36. In terms of profitability, MDRSF's ROE is +0.03%, compared to AVHHL's ROE of +4.77%. Regarding short-term risk, MDRSF and AVHHL have similar daily volatility (0.00).Check AVHHL's competition here
MDRSF vs SOMNF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, SOMNF has a market cap of 98.6M. Regarding current trading prices, MDRSF is priced at $115.00, while SOMNF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas SOMNF's P/E ratio is -45.00. In terms of profitability, MDRSF's ROE is +0.03%, compared to SOMNF's ROE of -0.05%. Regarding short-term risk, MDRSF and SOMNF have similar daily volatility (0.00).Check SOMNF's competition here
MDRSF vs JMDMF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, JMDMF has a market cap of 94.1M. Regarding current trading prices, MDRSF is priced at $115.00, while JMDMF trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas JMDMF's P/E ratio is -13.68. In terms of profitability, MDRSF's ROE is +0.03%, compared to JMDMF's ROE of N/A. Regarding short-term risk, MDRSF and JMDMF have similar daily volatility (0.00).Check JMDMF's competition here
MDRSF vs RSHUF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, MDRSF is priced at $115.00, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, MDRSF's ROE is +0.03%, compared to RSHUF's ROE of -4.12%. Regarding short-term risk, MDRSF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check RSHUF's competition here
MDRSF vs CKMTF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, MDRSF is priced at $115.00, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, MDRSF's ROE is +0.03%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, MDRSF and CKMTF have similar daily volatility (0.00).Check CKMTF's competition here
MDRSF vs BLOZF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, BLOZF has a market cap of 64.4M. Regarding current trading prices, MDRSF is priced at $115.00, while BLOZF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas BLOZF's P/E ratio is -13.12. In terms of profitability, MDRSF's ROE is +0.03%, compared to BLOZF's ROE of -3.03%. Regarding short-term risk, MDRSF is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check BLOZF's competition here
MDRSF vs TLTFF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, TLTFF has a market cap of 59.6M. Regarding current trading prices, MDRSF is priced at $115.00, while TLTFF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas TLTFF's P/E ratio is -21.61. In terms of profitability, MDRSF's ROE is +0.03%, compared to TLTFF's ROE of -3.15%. Regarding short-term risk, MDRSF is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check TLTFF's competition here
MDRSF vs NVYTF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, NVYTF has a market cap of 34.8M. Regarding current trading prices, MDRSF is priced at $115.00, while NVYTF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas NVYTF's P/E ratio is -0.86. In terms of profitability, MDRSF's ROE is +0.03%, compared to NVYTF's ROE of -0.73%. Regarding short-term risk, MDRSF and NVYTF have similar daily volatility (0.00).Check NVYTF's competition here
MDRSF vs RDGL Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, RDGL has a market cap of 29.5M. Regarding current trading prices, MDRSF is priced at $115.00, while RDGL trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas RDGL's P/E ratio is -6.12. In terms of profitability, MDRSF's ROE is +0.03%, compared to RDGL's ROE of -1.26%. Regarding short-term risk, MDRSF is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check RDGL's competition here
MDRSF vs MKEAF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, MDRSF is priced at $115.00, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, MDRSF's ROE is +0.03%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, MDRSF and MKEAF have similar daily volatility (0.00).Check MKEAF's competition here
MDRSF vs POSC Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, POSC has a market cap of 25.7M. Regarding current trading prices, MDRSF is priced at $115.00, while POSC trades at $1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas POSC's P/E ratio is -5.29. In terms of profitability, MDRSF's ROE is +0.03%, compared to POSC's ROE of -4.69%. Regarding short-term risk, MDRSF and POSC have similar daily volatility (0.00).Check POSC's competition here
MDRSF vs PYNKF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, PYNKF has a market cap of 25.2M. Regarding current trading prices, MDRSF is priced at $115.00, while PYNKF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas PYNKF's P/E ratio is 4.00. In terms of profitability, MDRSF's ROE is +0.03%, compared to PYNKF's ROE of -2.78%. Regarding short-term risk, MDRSF is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check PYNKF's competition here
MDRSF vs TCLIF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, TCLIF has a market cap of 25.1M. Regarding current trading prices, MDRSF is priced at $115.00, while TCLIF trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas TCLIF's P/E ratio is -4.84. In terms of profitability, MDRSF's ROE is +0.03%, compared to TCLIF's ROE of +2.39%. Regarding short-term risk, MDRSF is less volatile compared to TCLIF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check TCLIF's competition here
MDRSF vs KBBTF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, MDRSF is priced at $115.00, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, MDRSF's ROE is +0.03%, compared to KBBTF's ROE of N/A. Regarding short-term risk, MDRSF and KBBTF have similar daily volatility (0.00).Check KBBTF's competition here
MDRSF vs EMITF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, EMITF has a market cap of 21.3M. Regarding current trading prices, MDRSF is priced at $115.00, while EMITF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas EMITF's P/E ratio is -7.62. In terms of profitability, MDRSF's ROE is +0.03%, compared to EMITF's ROE of -0.07%. Regarding short-term risk, MDRSF and EMITF have similar daily volatility (0.00).Check EMITF's competition here
MDRSF vs VPTDF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, VPTDF has a market cap of 18.6M. Regarding current trading prices, MDRSF is priced at $115.00, while VPTDF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas VPTDF's P/E ratio is -4.95. In terms of profitability, MDRSF's ROE is +0.03%, compared to VPTDF's ROE of +0.78%. Regarding short-term risk, MDRSF and VPTDF have similar daily volatility (0.00).Check VPTDF's competition here
MDRSF vs DIZTF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, MDRSF is priced at $115.00, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, MDRSF's ROE is +0.03%, compared to DIZTF's ROE of -0.52%. Regarding short-term risk, MDRSF is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check DIZTF's competition here
MDRSF vs IPDQF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, IPDQF has a market cap of 16.3M. Regarding current trading prices, MDRSF is priced at $115.00, while IPDQF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas IPDQF's P/E ratio is -0.80. In terms of profitability, MDRSF's ROE is +0.03%, compared to IPDQF's ROE of -1.65%. Regarding short-term risk, MDRSF and IPDQF have similar daily volatility (0.00).Check IPDQF's competition here
MDRSF vs GTHP Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, GTHP has a market cap of 15.3M. Regarding current trading prices, MDRSF is priced at $115.00, while GTHP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas GTHP's P/E ratio is -5.00. In terms of profitability, MDRSF's ROE is +0.03%, compared to GTHP's ROE of +0.82%. Regarding short-term risk, MDRSF is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check GTHP's competition here
MDRSF vs MDXHF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, MDXHF has a market cap of 14.4M. Regarding current trading prices, MDRSF is priced at $115.00, while MDXHF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas MDXHF's P/E ratio is -4.40. In terms of profitability, MDRSF's ROE is +0.03%, compared to MDXHF's ROE of +0.58%. Regarding short-term risk, MDRSF and MDXHF have similar daily volatility (0.00).Check MDXHF's competition here
MDRSF vs TMDIF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, MDRSF is priced at $115.00, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, MDRSF's ROE is +0.03%, compared to TMDIF's ROE of +8.70%. Regarding short-term risk, MDRSF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check TMDIF's competition here
MDRSF vs ASAPF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, ASAPF has a market cap of 13.8M. Regarding current trading prices, MDRSF is priced at $115.00, while ASAPF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas ASAPF's P/E ratio is -17.65. In terms of profitability, MDRSF's ROE is +0.03%, compared to ASAPF's ROE of -0.19%. Regarding short-term risk, MDRSF and ASAPF have similar daily volatility (0.00).Check ASAPF's competition here
MDRSF vs ATBPF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, MDRSF is priced at $115.00, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, MDRSF's ROE is +0.03%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, MDRSF is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check ATBPF's competition here
MDRSF vs LXXGF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, MDRSF is priced at $115.00, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, MDRSF's ROE is +0.03%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, MDRSF and LXXGF have similar daily volatility (0.00).Check LXXGF's competition here
MDRSF vs ALRTF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, ALRTF has a market cap of 10.6M. Regarding current trading prices, MDRSF is priced at $115.00, while ALRTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas ALRTF's P/E ratio is -0.42. In terms of profitability, MDRSF's ROE is +0.03%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, MDRSF and ALRTF have similar daily volatility (0.00).Check ALRTF's competition here
MDRSF vs BIEL Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, BIEL has a market cap of 8.1M. Regarding current trading prices, MDRSF is priced at $115.00, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas BIEL's P/E ratio is N/A. In terms of profitability, MDRSF's ROE is +0.03%, compared to BIEL's ROE of +0.05%. Regarding short-term risk, MDRSF is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check BIEL's competition here
MDRSF vs PLLWF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, PLLWF has a market cap of 8M. Regarding current trading prices, MDRSF is priced at $115.00, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas PLLWF's P/E ratio is -0.66. In terms of profitability, MDRSF's ROE is +0.03%, compared to PLLWF's ROE of -0.99%. Regarding short-term risk, MDRSF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check PLLWF's competition here
MDRSF vs PMEDF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, PMEDF has a market cap of 7.5M. Regarding current trading prices, MDRSF is priced at $115.00, while PMEDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas PMEDF's P/E ratio is -3.64. In terms of profitability, MDRSF's ROE is +0.03%, compared to PMEDF's ROE of +1.24%. Regarding short-term risk, MDRSF is less volatile compared to PMEDF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check PMEDF's competition here
MDRSF vs USAQ Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, USAQ has a market cap of 7.5M. Regarding current trading prices, MDRSF is priced at $115.00, while USAQ trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas USAQ's P/E ratio is 33.00. In terms of profitability, MDRSF's ROE is +0.03%, compared to USAQ's ROE of -8.25%. Regarding short-term risk, MDRSF is less volatile compared to USAQ. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check USAQ's competition here
MDRSF vs ADMT Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, ADMT has a market cap of 5.6M. Regarding current trading prices, MDRSF is priced at $115.00, while ADMT trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas ADMT's P/E ratio is -8.35. In terms of profitability, MDRSF's ROE is +0.03%, compared to ADMT's ROE of -0.01%. Regarding short-term risk, MDRSF is less volatile compared to ADMT. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check ADMT's competition here
MDRSF vs RMSL Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, RMSL has a market cap of 5.6M. Regarding current trading prices, MDRSF is priced at $115.00, while RMSL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas RMSL's P/E ratio is 0.33. In terms of profitability, MDRSF's ROE is +0.03%, compared to RMSL's ROE of -17961324.55%. Regarding short-term risk, MDRSF is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check RMSL's competition here
MDRSF vs QLIS Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, MDRSF is priced at $115.00, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas QLIS's P/E ratio is 2.22. In terms of profitability, MDRSF's ROE is +0.03%, compared to QLIS's ROE of -0.77%. Regarding short-term risk, MDRSF and QLIS have similar daily volatility (0.00).Check QLIS's competition here
MDRSF vs RHNMF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, MDRSF is priced at $115.00, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, MDRSF's ROE is +0.03%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, MDRSF is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check RHNMF's competition here
MDRSF vs ODYY Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, ODYY has a market cap of 4.3M. Regarding current trading prices, MDRSF is priced at $115.00, while ODYY trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas ODYY's P/E ratio is -0.86. In terms of profitability, MDRSF's ROE is +0.03%, compared to ODYY's ROE of +0.58%. Regarding short-term risk, MDRSF is less volatile compared to ODYY. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check ODYY's competition here
MDRSF vs VANIW Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, MDRSF is priced at $115.00, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas VANIW's P/E ratio is N/A. In terms of profitability, MDRSF's ROE is +0.03%, compared to VANIW's ROE of -3.17%. Regarding short-term risk, MDRSF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check VANIW's competition here
MDRSF vs CYDX Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, CYDX has a market cap of 3.2M. Regarding current trading prices, MDRSF is priced at $115.00, while CYDX trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas CYDX's P/E ratio is 0.79. In terms of profitability, MDRSF's ROE is +0.03%, compared to CYDX's ROE of +0.13%. Regarding short-term risk, MDRSF and CYDX have similar daily volatility (0.00).Check CYDX's competition here
MDRSF vs NGMDF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, NGMDF has a market cap of 2.9M. Regarding current trading prices, MDRSF is priced at $115.00, while NGMDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas NGMDF's P/E ratio is -1.27. In terms of profitability, MDRSF's ROE is +0.03%, compared to NGMDF's ROE of +0.94%. Regarding short-term risk, MDRSF and NGMDF have similar daily volatility (0.00).Check NGMDF's competition here
MDRSF vs TBRIF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, TBRIF has a market cap of 2.8M. Regarding current trading prices, MDRSF is priced at $115.00, while TBRIF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas TBRIF's P/E ratio is -0.96. In terms of profitability, MDRSF's ROE is +0.03%, compared to TBRIF's ROE of +2.92%. Regarding short-term risk, MDRSF and TBRIF have similar daily volatility (0.00).Check TBRIF's competition here
MDRSF vs VYCO Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, VYCO has a market cap of 2.3M. Regarding current trading prices, MDRSF is priced at $115.00, while VYCO trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas VYCO's P/E ratio is -6.99. In terms of profitability, MDRSF's ROE is +0.03%, compared to VYCO's ROE of +0.02%. Regarding short-term risk, MDRSF and VYCO have similar daily volatility (0.00).Check VYCO's competition here
MDRSF vs FZMD Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, FZMD has a market cap of 2M. Regarding current trading prices, MDRSF is priced at $115.00, while FZMD trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas FZMD's P/E ratio is 1.35. In terms of profitability, MDRSF's ROE is +0.03%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, MDRSF and FZMD have similar daily volatility (0.00).Check FZMD's competition here
MDRSF vs LLBO Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, LLBO has a market cap of 1.7M. Regarding current trading prices, MDRSF is priced at $115.00, while LLBO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas LLBO's P/E ratio is N/A. In terms of profitability, MDRSF's ROE is +0.03%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, MDRSF is less volatile compared to LLBO. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check LLBO's competition here
MDRSF vs NUMD Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, NUMD has a market cap of 1.5M. Regarding current trading prices, MDRSF is priced at $115.00, while NUMD trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas NUMD's P/E ratio is 1.74. In terms of profitability, MDRSF's ROE is +0.03%, compared to NUMD's ROE of +0.22%. Regarding short-term risk, MDRSF and NUMD have similar daily volatility (0.00).Check NUMD's competition here
MDRSF vs ESMC Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, ESMC has a market cap of 1.3M. Regarding current trading prices, MDRSF is priced at $115.00, while ESMC trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas ESMC's P/E ratio is -5.67. In terms of profitability, MDRSF's ROE is +0.03%, compared to ESMC's ROE of -125.28%. Regarding short-term risk, MDRSF and ESMC have similar daily volatility (0.00).Check ESMC's competition here
MDRSF vs KLYG Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, KLYG has a market cap of 1.3M. Regarding current trading prices, MDRSF is priced at $115.00, while KLYG trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas KLYG's P/E ratio is -10.00. In terms of profitability, MDRSF's ROE is +0.03%, compared to KLYG's ROE of -0.19%. Regarding short-term risk, MDRSF is less volatile compared to KLYG. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check KLYG's competition here
MDRSF vs UAHC Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, UAHC has a market cap of 777.5K. Regarding current trading prices, MDRSF is priced at $115.00, while UAHC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas UAHC's P/E ratio is 0.56. In terms of profitability, MDRSF's ROE is +0.03%, compared to UAHC's ROE of +0.04%. Regarding short-term risk, MDRSF and UAHC have similar daily volatility (0.00).Check UAHC's competition here
MDRSF vs VRSEF Comparison May 2026
MDRSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MDRSF stands at 1.4B. In comparison, VRSEF has a market cap of 747.9K. Regarding current trading prices, MDRSF is priced at $115.00, while VRSEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MDRSF currently has a P/E ratio of 135.29, whereas VRSEF's P/E ratio is 0.07. In terms of profitability, MDRSF's ROE is +0.03%, compared to VRSEF's ROE of -0.29%. Regarding short-term risk, MDRSF is less volatile compared to VRSEF. This indicates potentially lower risk in terms of short-term price fluctuations for MDRSF.Check VRSEF's competition here